Evidence map›Paper›PMID 39849118›Full record

Observational studyGraefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie2025

Analysis of choroidal markers of activity in pachychoroid disease spectrum.

Raphaela M Fuganti, Fernando Campiolo, Ahmad Mansour, Luiz H Lima, Mauricio Maia, Antonio Marcelo Casella

Abstract readObservational Study
PubMed Publisher
In one paragraph

Observational study in Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Pachychoroid diseases of the macula: an update.Medical hypothesis, discovery & innovation ophthalmology journal · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Raphaela M Fuganti *Londrina State University, Avenida Robert Koch, 60, Londrina, CEP 86038-440, Paraná, Brazil.ORCID http://orcid.org/0000-0003-3167-2195
Fernando Campiolo *Londrina State University, Avenida Robert Koch, 60, Londrina, CEP 86038-440, Paraná, Brazil.ORCID http://orcid.org/0000-0002-1145-0125
Ahmad MansourAmerican University of Beirut, Riad El-Soth, Beirut, 11072020, Lebanon.ORCID http://orcid.org/0000-0001-8430-2214
Luiz H LimaFederal University of São Paulo, R. Sena Madureira, São Paulo, 1500, CEP 04021-001, Brazil.ORCID http://orcid.org/0000-0001-7304-909X
Mauricio MaiaFederal University of São Paulo, R. Sena Madureira, São Paulo, 1500, CEP 04021-001, Brazil.ORCID http://orcid.org/0000-0002-7034-8091
Antonio Marcelo CasellaLondrina State University, Avenida Robert Koch, 60, Londrina, CEP 86038-440, Paraná, Brazil. mbcasella@gmail.com.ORCID http://orcid.org/0000-0002-4552-2799

Funding

CAPES R$ 2.000
6 · The paper itself

Abstract

purposeTo detect choroidal markers of disease activity in eyes with chronic active unilateral pachychoroid disease spectrum (PDS) compared to the non-active contralateral eyes, based on multimodal imaging and particularly indocyanine green angiography (ICGA).

methodsAn observational retrospective case-control study. The study evaluated individuals diagnosed with chronic active unilateral PDS (group 1) by comparing the eyes with the non-active fellow eyes (group 2). Imaging was performed using fundus photographs, ICGA, and spectral-domain optical coherence tomography (SD-OCT). Choroidal thickness, choroidal vascular density, choroidal vasodilation, choroidal vascular leakage, and choroidal meridian breakdown were evaluated.

resultsOf the 90 patients with chronic PDS with ICGA at our database, 27 Caucasians (mean age: 55.9 years) were identified with active unilateral PDS. Group 1 showed a higher prevalence of the following parameters compared to Group 2: choroidal meridian breakdown (81.5% vs. 25.9%; p < 0.001), choroidal vasodilation (88.9% vs. 48.1%; p < 0.001), greater subfoveal choroidal thickness (420 ± 79.8 μm vs. 346 ± 78.5 μm; p = 0.002), ICGA choroidal vascular leakage (96.3% vs. 29.6%; p < 0.001), and choroidal hyperpermeability (100% vs. 29.6%; p < 0.001), with a nonsignificant increase in choroidal vascular density (55.4%±13.4 vs. 49.3%±13.5 in the contralateral eye; p = 0.167).

conclusionChoroidal meridian breakdown, thicker choroid, choroidal vasodilation, and ICGA choroidal vascular leakage are potential posterior choroidal markers of disease activity in PDS.

Indexed as

ChoroidChoroid DiseasesFluorescein AngiographyTomography, Optical CoherenceAdultAgedCase-Control StudiesChronic DiseaseColoring AgentsFemaleFollow-Up StudiesFundus OculiHumansIndocyanine GreenMaleMiddle AgedColoring AgentsIndocyanine GreenChoroidal circulationChoroidal thicknessPachychoroidPachychoroid disease spectrum

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.